Načítá se...
Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device
Background: Aerosol drug delivery to the lungs is known to be very inefficient during all forms of noninvasive ventilation, especially when the aerosol is administered simultaneously with high-flow nasal cannula (HFNC) therapy. The objective of this study was to develop a new combination device base...
Uloženo v:
| Vydáno v: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc., publishers
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685196/ https://ncbi.nlm.nih.gov/pubmed/30855199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2018.1488 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|